Study design and participants
stroke
STROKE
This study was a parallel, double-blind, placebo-controlled clinical trial to evaluate the effectiveness of curcumin-piperine supplementation in patients with stroke. Participants were recruited from Imam Musa Sadr Clinic, affiliated with Isfahan University of Medical Sciences, Isfahan, Iran from December 2020 to December 2021. The Ethics Committee of Isfahan University of Medical Sciences approved this project with the approval number IR.MUI.RESEARCH.REC.1399.593. This trial was registered with the Iranian Registry of Clinical Trials with ID: IRCT20121216011763N48. This study was performed based on the Helsinki Declaration. Written informed consent was obtained from all participants before the study.